Last 7.63 GBp
Change Today +0.375 / 5.17%
Volume 1.2M
DEMG On Other Exchanges
Symbol
Exchange
London
OTC US
Frankfurt
As of 11:30 AM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

deltex medical group plc (DEMG) Snapshot

Open
7.25 GBp
Previous Close
7.25 GBp
Day High
7.63 GBp
Day Low
7.25 GBp
52 Week High
10/29/13 - 16.88 GBp
52 Week Low
10/22/14 - 7.13 GBp
Market Cap
16.2M
Average Volume 10 Days
453.5K
EPS TTM
-0.01 GBp
Shares Outstanding
212.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DELTEX MEDICAL GROUP PLC (DEMG)

Related News

No related news articles were found.

deltex medical group plc (DEMG) Related Businessweek News

No Related Businessweek News Found

deltex medical group plc (DEMG) Details

Deltex Medical Group plc is engaged in the research, development, manufacture, and sale of oesophageal Doppler haemodynamic monitoring (ODM) systems in the United Kingdom, the United States, Spain, and internationally. It offers CardioQ-ODM that allows clinicians to guide fluid and drug administration during surgery and critical care; CardioQ-ODM+, a fluid management and cardiac output monitoring system to measure flow and pressure directly; oesophageal Doppler probes; and USCOM 1A monitor, a non-invasive device for high resolution measurement of the haemodynamic circulation. The company is based in Chichester, the United Kingdom.

84 Employees
Last Reported Date: 03/11/14

deltex medical group plc (DEMG) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: 185.0K GBP
Finance Director, Secretary and Executive Dir...
Total Annual Compensation: 106.5K GBP
Compensation as of Fiscal Year 2013.

deltex medical group plc (DEMG) Key Developments

Deltex Medical Group plc Plans to Build Strong Platform for Medium Term National Roll-Out in the USA in the Second Half of 2014; Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2014

Deltex Medical Group plc planned to build strong platform for medium term national roll-out in the USA in the second half of 2014. The company announced unaudited consolidated earnings results for the six months ended June 30, 2014. For the period, the company's total revenue was £2.95 million compared with £2.92 million a year ago. Operating loss was £1.52 million compared with £1.38 million a year ago. Losses are traditionally significantly higher in the first half than the second due to the timing of many larger International orders and this trend has been exacerbated in 2014 by the slow-down in the UK market with the effect of actions taken in response expected to come through in the second half. Loss before taxation was £1.58 million compared with £1.44 million a year ago. Loss for the period was £1.52 million or 0.9 pence per basic and diluted share compared with £1.39 million or 0.9 pence per basic and diluted share a year ago.Net cash used in operating activities was £0.57 million compared with £1.26 million a year ago. Purchase of property, plant and equipment was £0.15 million compared with £0.13 million a year ago. Capitalized development expenditure was £0.23 million compared with £0.21 million a year ago. Pro-forma total probe revenue was £2.54 million compared with £2.65 million a year ago. Pro-forma operating loss was £1.52 million compared with £1.38 million a year ago.

Deltex Medical Group plc Provides Sales Guidance for the Six Months Ended June 30, 2014

Deltex Medical Group plc provided sales guidance for the six months ended June 30, 2014. For the period, the company expects group sales for statutory reporting purposes to be circa £3.0 million against £2.9 million for the same period a year ago.

Deltex Medical Group plc to Report First Half, 2014 Results on Sep 11, 2014

Deltex Medical Group plc announced that they will report first half, 2014 results on Sep 11, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DEMG:LN 7.63 GBp +0.375

DEMG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Edwards Lifesciences Corp $116.76 USD +11.57
LiDCO Group PLC 13.50 GBp +0.25
Masimo Corp $22.33 USD +0.11
Pulsion Medical Systems SE €19.72 EUR -0.054
View Industry Companies
 

Industry Analysis

DEMG

Industry Average

Valuation DEMG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 2.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DELTEX MEDICAL GROUP PLC, please visit www.deltexmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.